NeoGraph Analytics
Medical ImagingEast Asia2023 – 2032

Global Asia Pacific Medical Imaging AI Market Analysis, Opportunities and Forecast 2024-2032

Asia Pacific Medical Imaging AI Market valued at USD 2.4B in 2023, projected to reach USD 14.9B by 2032 at 22.5% CAGR.

Revenue, 2023

$2.4B

Forecast, 2032

$14.9B

CAGR, 2024-2032

22.5%

Report Coverage

East Asia

Code: asia-pacific-medical-imaging-ai-marketPublished: 2026Pages: 150+Format: PDF + Excel
01

Executive Summary

The Asia Pacific Medical Imaging AI market was valued at USD 2.4 billion in 2023 and is projected to reach USD 14.9 billion by 2032, growing at a 22.5% CAGR. China dominates with 38% regional share, driven by government digital health mandates and large hospital networks. Japan and India represent high-growth secondary markets at 18% and 28% CAGR respectively. Key players include GE Healthcare, Siemens Healthineers, and Infervision. Radiology applications command 45% of segment revenue. Regulatory harmonization across APAC and rising chronic disease burden are primary growth catalysts.

02

Key Highlights

1

Market projected to grow from USD 2.4B to USD 14.9B at 22.5% CAGR through 2032.

2

China leads APAC with 38% market share, supported by government healthcare digitization policies.

3

Radiology segment dominates at 45% share; oncology is fastest-growing application at 20% CAGR.

4

Infervision, Viz.ai, and Shukun emerge as top APAC-native AI imaging startups.

5

Regulatory frameworks in China and Japan accelerating AI medical device approvals significantly.

03

Market Overview

Market Context

Medical imaging AI integrates artificial intelligence with diagnostic imaging technologies to enhance accuracy, speed, and clinical outcomes. The Asia Pacific region is experiencing rapid adoption driven by expanding healthcare infrastructure, increasing radiologist shortages, and government-backed digital health initiatives.

The Asia Pacific Medical Imaging AI market is experiencing rapid growth driven by expanding healthcare infrastructure, radiologist shortages, and government-backed digital health initiatives. China leads adoption while India and Southeast Asia represent high-growth frontiers. The market is in a high-growth phase with mainstream adoption expected by 2030.

Market Stage

High growth

Adoption Level

Growing

Key Trends

Cloud-based AI imaging platforms replacing on-premise deployments across APAC hospitals.Generative AI enabling enhanced 3D reconstruction and surgical planning in radiology.Government mandates in China and Japan accelerating AI medical device regulatory approvals.Rising partnerships between global OEMs and local APAC AI startups for market expansion.
04

Market Forecast & Data

Market Growth Forecast
2024-2032 · CAGR 22.5%

Base Year (2023)

$2.4B

Forecast (2032)

$14.9B

CAGR (2024-2032)

22.5%

Market size by year, 2024-2032, in USD Billion.
YearMarket size ($ Billion)
2023Base year$2.40B
2024$2.94B
2025$3.60B
2026$4.41B
2027$5.40B
2028$6.62B
2029$8.11B
2030$9.93B
2031$12.17B
2032$14.91B
Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.
Forecast Analysis

The market is forecast to grow from USD 2.4B in 2023 to USD 14.9B by 2032 at a 22.5% CAGR. China and India will collectively contribute over 50% of regional revenue by 2032. Cloud-based AI solutions will outpace on-premise deployments. Regulatory approvals are accelerating across key APAC markets.

Regional Market Analysis
Market share and growth rate by region
Regional market analysis — market share, growth rate and largest market by region.
RegionMarket shareGrowth rateLargest market
East Asia55.0%22.0%China
South Asia20.0%28.0%India
Southeast Asia15.0%20.0%Singapore
Oceania10.0%16.0%Australia

East Asia

#1
Share: 55.0%CAGR: 22.0%

Largest market: China

South Asia

#2
Share: 20.0%CAGR: 28.0%

Largest market: India

Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.
05

Market Dynamics

  • Rising radiologist shortage across APAC increasing reliance on AI-assisted diagnostics.
  • Government investments in digital health infrastructure and AI adoption mandates.
  • Growing cancer and cardiovascular disease burden requiring faster, accurate imaging.
06

Market Segmentation

By Technology
Market share distribution across 4 segments
By Technology — market share by segment, in percent.
SegmentShare
Computer VisionDominant technology for image recognition, anomaly detection, and automated reporting in radiology and pathology.40.0%
Deep LearningNeural network-based models enabling advanced diagnostic accuracy in CT, MRI, and X-ray interpretation.35.0%
Natural Language ProcessingUsed for extracting clinical insights from radiology reports and structuring unstructured imaging data.15.0%
Machine LearningTraditional ML algorithms applied to imaging biomarkers and predictive analytics for treatment planning.10.0%
Total100.0%
Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.
By Application
Market share distribution across 5 segments
By Application — market share by segment, in percent.
SegmentShare
RadiologyLargest application segment driven by AI-assisted CT, MRI, and X-ray interpretation in hospitals.45.0%
CardiologyAI-enabled echocardiography, coronary CT angiography, and cardiac MRI analysis gaining rapid adoption.20.0%
OncologyFastest-growing segment with AI-powered tumor detection, segmentation, and treatment response monitoring.18.0%
NeurologyAI applications in stroke detection, brain tumor analysis, and neurodegenerative disease screening.12.0%
OthersIncludes musculoskeletal, breast imaging, and ophthalmic AI applications.5.0%
Total100.0%
Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.

By End User

  • Hospitals
  • Diagnostic Centers
  • Research Institutes
07

Regional Analysis

1

East Asia

Lead: China
CAGR: 22.0%Share: 55.0%

Largest sub-region led by China and Japan with advanced healthcare infrastructure and strong government AI mandates.

2

South Asia

Lead: India
CAGR: 28.0%Share: 20.0%

Fastest-growing sub-region driven by expanding hospital networks, rising chronic disease prevalence, and cost-effective AI adoption.

3

Southeast Asia

Lead: Singapore
CAGR: 20.0%Share: 15.0%

Emerging market with increasing healthcare digitization and growing demand for AI-powered diagnostic solutions.

4

Oceania

Lead: Australia
CAGR: 16.0%Share: 10.0%

Mature healthcare system adopting AI imaging solutions primarily in radiology and oncology departments.

Country-Level Analysis

Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.
Market share and growth rate by country
CountryShareGrowth
China
38.0%
+25.0%
Japan
20.0%
+18.0%
India
15.0%
+28.0%
08

Competitive Landscape

G

GE Healthcare

United States

Leader19.6B

Dominates APAC medical imaging AI with Edison platform, TrueFidelity CT, and AI Orchestrator solutions backed by extensive installed base.

Global leader in medical imaging AI with Edison platform, TrueFidelity CT, and AI Orchestrator deployed across APAC hospitals.

S

Siemens Healthineers

Germany

Challenger22.4B

Strong AI-powered radiology suite with AI-Rad Companion, growing APAC presence through partnerships with regional healthcare providers.

Germany-based medtech giant offering AI-Rad Companion and AI-powered imaging suites with growing APAC diagnostic partnerships.

I

Infervision Medical Technology

China

Follower150M

Leading China-based AI imaging startup with NMPA-cleared products for chest CT and stroke detection, expanding across Southeast Asia.

Beijing-based AI startup specializing in NMPA-cleared medical imaging AI for chest CT, stroke, and cancer screening across APAC.

09

Recent Developments

25
2025Infervision Medical Technology

Received NMPA clearance for AI-powered chest CT solution and expanded distribution across Southeast Asia.

24
2024Siemens Healthineers

Launched AI-powered radiology suite in Japan targeting aging population diagnostic needs.

10

Regulatory Landscape

China NMPA AI Medical Device Classification and Approval Guidelines (2024 update)Japan PMDA AI/SaMD Regulatory Framework for Expedited Review Pathway
11

Research Methodology

Primary research

  • Expert interviews
  • Surveys

Secondary research

  • Industry reports
  • Company financials

Validation: Triangulation method

12

Strategic Takeaways

Investors

Target AI imaging platforms with multi-modal capabilities and regulatory approvals in China and Japan for highest ROI.

Operators

Prioritize cloud-based AI solutions and partnerships with local APAC distributors to accelerate market penetration.

Policymakers

Develop harmonized APAC regulatory frameworks to facilitate cross-border AI medical device approvals and data sharing.

13

Frequently Asked Questions

Reports in the same field, each with its base-year figure and the growth rate it is published at.